Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 26 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

12%

3 trials in Phase 3/4

Results Transparency

17%

3 of 18 completed with results

Key Signals

3 with results100% success

Data Visualizations

Phase Distribution

25Total
Not Applicable (5)
P 2 (17)
P 3 (3)

Trial Status

Completed18
Active Not Recruiting3
Not Yet Recruiting2
Withdrawn1
Recruiting1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 18 completed trials

Clinical Trials (26)

Showing 20 of 20 trials
NCT06648850Phase 2Not Yet Recruiting

Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth

NCT06972264Phase 3Active Not Recruiting

Safety and Efficacy of VDPHL01 in Males With AGA

NCT06527365Phase 2Active Not Recruiting

Safety and Efficacy of VDPHL01 in Males and Females With AGA

NCT06724614Phase 2Active Not Recruiting

Efficacy and Safety of VDPHL01 in Males With AGA

NCT06924632Phase 3Recruiting

Efficacy & Safety of Minoxidil SL Tablets in Men With AGA

NCT05970809Not ApplicableCompletedPrimary

Assessing the Safety and Efficacy of a Novel Microneedling and Laser Device for Male Pattern Hair Loss

NCT06501924Phase 3Not Yet Recruiting

Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss

NCT03852992Phase 2Withdrawn

Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia

NCT05450861Not ApplicableCompleted

Effect of the Composition From Fish on Promoting Hair Growth

NCT04898166Completed

Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019 (COVID-19).

NCT03938948Not ApplicableUnknownPrimary

Low Level Light Therapy (LLLT) for Hair Growth

NCT01451112Phase 2Completed

A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002899)

NCT01451125Phase 2Completed

A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004512)

NCT01451138Phase 2Completed

A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004541)

NCT01451177Phase 2Completed

A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004669)

NCT01451190Phase 2Completed

A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0005995)

NCT01669746Phase 2Completed

A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0006931)

NCT01451151Phase 2Completed

A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004542)

NCT00947219Not ApplicableCompleted

Treatment of Androgenic Alopecia in Males

NCT01548066Phase 2Completed

The Efficacy and Safety of Topical Valproic Acid in Preventing Hair Loss

Scroll to load more

Research Network

Activity Timeline